Russia’s Roszdravnadzor raises concerns about phantom drug wholesale companies
This article was originally published in RAJ Devices
During a country-wide inspection carried out in July and August 2008, the Russian Service for the Surveillance of Healthcare and Social Development (Roszdravnadzor) has discovered over 60 drug wholesale companies that do not provide their services in places stipulated in their licences. This, the authority believes, could mean that these firms are involved in criminal activities having the potential to put patients’ health at risk. In light of an ongoing discussion in Russia about cutting licensing requirements to eliminate bureaucratic barriers, Roszdravnadzor suggests that the drug distribution market is not ready for control over the sector to be relaxed in order to ease entry to the market.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.